The digital therapeutics market is projected to witness significant growth from 2025 to 2035. Digital therapeutics (DTx) are gaining demand due to their potential for cost-effective, scalable, and evidence-based treatment options, especially for chronic diseases. Valued at approximately USD 6.7 billion in 2025, the market is anticipated to reach USD 42.1 billion by 2035, reflecting a strong compound annual growth rate (CAGR) of 18.5% over the ten-year period.